It certainly wouldn't be inappropriate for executives at Toyota's world headquarters in Japan to affix a plaque with this statement at the main corporate entrance: The best of times, the worst of times.
Who truly advocates for nursing home residents in New Jersey and across the United States when they face issues of nursing home negligence or abuse?
Please see our immediately preceding products liability blog post of this past Tuesday for relevant background information regarding the FDA's recent issuance of a proposed order aimed at manufacturers of metal-on-metal (MOM) hip implants. The instant post serves as a tandem communication on that subject and provides readers with additional information on the order and the history leading up to it.
The following information concerning hip implants will be supplemented later this week in a follow-up products liability post that allows for necessary amplification of the subject matter.
Many readers undoubtedly remember all too well the fatal air crash of Colgan Air Flight 3407 in early February 2009, a flight departing from New Jersey and destined for Buffalo, New York.
New Jersey and other users nationwide of the pharmaceutical drug Synthroid might want to pay close attention to drug company AbbVie Inc.'s recent voluntary recall of the thyroid-hormone replacement therapy.
If you spend more money on diagnostic screenings for breast cancer, that should logically equate to more accurate diagnoses and, ultimately, less money expended on treatment.
Hurricane Sandy was obviously unprecedented, with its effects widespread and far-reaching for literally millions of people in New Jersey, New York and other eastern states.
Too much or too little?
The anti-depressant drug Zoloft has been a prime cash generator for the pharmaceutical giant Pfizer since it first received approval from the FDA for use in the United States in 1991.